# KLA Corporation timeline

entity: /record/kla.md  
id: ent_kla  

KLA Corporation's timeline holds 516 claims from 1994 to 2026: 2 people, 504 money & deals, 10 other. 7 are undated. The latest took effect on October 26, 2026.

Kinds: People 2 (/timelines/kla.md?kind=people) · Money & deals 504 (/timelines/kla.md?kind=money) · Products 0 (/timelines/kla.md?kind=products) · Models 0 (/timelines/kla.md?kind=models) · Other 10 (/timelines/kla.md?kind=other)  
Format: date | kind | predicate | value | status | claim.

## 1994

- 1994-01-26 to 1997-02-11 | other | registrant_name | KLA INSTRUMENTS CORP | superseded | [clm_1F40EB3477DF](/claim/clm_1F40EB3477DF.md)

## 1997

- 1997-09-10 to 2019-07-03 | other | registrant_name | KLA TENCOR CORP | superseded | [clm_10F58BD9AA09](/claim/clm_10F58BD9AA09.md)

## 2008

- 2008-06-30 to 2009-06-30 | money | cash_and_equivalents | 1,128,106,000 United States dollar | superseded | [clm_82C1C6F75C92](/claim/clm_82C1C6F75C92.md)
- 2008-06-30 to 2009-06-30 | money | total_equity | 2,981,730,000 United States dollar | superseded | [clm_7C09DBE20B7B](/claim/clm_7C09DBE20B7B.md)

## 2009

- 2009-06-30 to 2009-09-30 | money | cash_and_equivalents | 524,967,000 United States dollar | superseded | [clm_7B8E87E6DAD6](/claim/clm_7B8E87E6DAD6.md)
- 2009-06-30 to 2010-06-30 | money | net_income | -523,368,000 United States dollar | superseded | [clm_E47D0177BCDF](/claim/clm_E47D0177BCDF.md)
- 2009-06-30 to 2010-06-30 | money | operating_income | -577,941,000 United States dollar | superseded | [clm_9DF5D7A3C6C4](/claim/clm_9DF5D7A3C6C4.md)
- 2009-06-30 to 2010-06-30 | money | research_and_development | 371,463,000 United States dollar | superseded | [clm_F48235824042](/claim/clm_F48235824042.md)
- 2009-06-30 to 2010-06-30 | money | revenue | 1,520,216,000 United States dollar | superseded | [clm_2038B50A3BD6](/claim/clm_2038B50A3BD6.md)
- 2009-06-30 to 2010-06-30 | money | total_equity | 2,184,392,000 United States dollar | superseded | [clm_6BD194DA83CB](/claim/clm_6BD194DA83CB.md)
- 2009-09-30 to 2009-12-31 | money | cash_and_equivalents | 540,839,000 United States dollar | superseded | [clm_42DCEE5C42F1](/claim/clm_42DCEE5C42F1.md)
- 2009-09-30 to 2009-12-31 | money | quarterly_net_income | 20,405,000 United States dollar | superseded | [clm_42D871B801EF](/claim/clm_42D871B801EF.md)
- 2009-09-30 to 2009-12-31 | money | quarterly_operating_income | 14,950,000 United States dollar | superseded | [clm_948201D4A948](/claim/clm_948201D4A948.md)
- 2009-09-30 to 2009-12-31 | money | quarterly_research_and_development | 78,209,000 United States dollar | superseded | [clm_F6E9C7A8F070](/claim/clm_F6E9C7A8F070.md)
- 2009-09-30 to 2009-12-31 | money | quarterly_revenue | 342,687,000 United States dollar | superseded | [clm_62923F7500A3](/claim/clm_62923F7500A3.md)
- 2009-12-31 to 2010-03-31 | money | cash_and_equivalents | 531,444,000 United States dollar | superseded | [clm_B350E06682A9](/claim/clm_B350E06682A9.md)
- 2009-12-31 to 2010-03-31 | money | quarterly_net_income | 21,794,000 United States dollar | superseded | [clm_0160AC8A8A89](/claim/clm_0160AC8A8A89.md)
- 2009-12-31 to 2010-03-31 | money | quarterly_operating_income | 47,095,000 United States dollar | superseded | [clm_4253E2CD4C75](/claim/clm_4253E2CD4C75.md)
- 2009-12-31 to 2010-03-31 | money | quarterly_research_and_development | 83,301,000 United States dollar | superseded | [clm_3B2DA79F57C5](/claim/clm_3B2DA79F57C5.md)
- 2009-12-31 to 2010-03-31 | money | quarterly_revenue | 440,355,000 United States dollar | superseded | [clm_A6EE499C11C5](/claim/clm_A6EE499C11C5.md)

## 2010

- 2010-03-31 to 2010-06-30 | money | cash_and_equivalents | 543,505,000 United States dollar | superseded | [clm_A1C66C1C651D](/claim/clm_A1C66C1C651D.md)
- 2010-03-31 to 2010-09-30 | money | quarterly_net_income | 57,016,000 United States dollar | superseded | [clm_9CC1107FA55F](/claim/clm_9CC1107FA55F.md)
- 2010-03-31 to 2010-09-30 | money | quarterly_operating_income | 91,279,000 United States dollar | superseded | [clm_8EE9B4292633](/claim/clm_8EE9B4292633.md)
- 2010-03-31 to 2010-09-30 | money | quarterly_research_and_development | 84,741,000 United States dollar | superseded | [clm_5F97F8257C07](/claim/clm_5F97F8257C07.md)
- 2010-03-31 to 2010-09-30 | money | quarterly_revenue | 478,299,000 United States dollar | superseded | [clm_D8B6A3401388](/claim/clm_D8B6A3401388.md)
- 2010-06-30 to 2010-09-30 | money | cash_and_equivalents | 529,918,000 United States dollar | superseded | [clm_0E8128675F61](/claim/clm_0E8128675F61.md)
- 2010-06-30 to 2011-06-30 | money | net_income | 212,300,000 United States dollar | superseded | [clm_0C0C7AD3B11F](/claim/clm_0C0C7AD3B11F.md)
- 2010-06-30 to 2011-06-30 | money | operating_income | 314,166,000 United States dollar | superseded | [clm_EBD2BA2E7EF4](/claim/clm_EBD2BA2E7EF4.md)
- 2010-06-30 to 2011-06-30 | money | research_and_development | 329,560,000 United States dollar | superseded | [clm_EC5A0ABFDD85](/claim/clm_EC5A0ABFDD85.md)
- 2010-06-30 to 2011-06-30 | money | revenue | 1,820,760,000 United States dollar | superseded | [clm_BE8EDC3A5223](/claim/clm_BE8EDC3A5223.md)
- 2010-06-30 to 2010-09-30 | money | total_assets | 3,907,056,000 United States dollar | superseded | [clm_846F1E8C2C17](/claim/clm_846F1E8C2C17.md)
- 2010-06-30 to 2010-09-30 | money | total_equity | 2,246,611,000 United States dollar | superseded | [clm_2D3B66AF2E1E](/claim/clm_2D3B66AF2E1E.md)
- 2010-09-30 to 2010-12-31 | money | cash_and_equivalents | 538,384,000 United States dollar | superseded | [clm_A771A75E1C83](/claim/clm_A771A75E1C83.md)
- 2010-09-30 to 2010-12-31 | money | quarterly_net_income | 154,196,000 United States dollar | superseded | [clm_D479D1D80B49](/claim/clm_D479D1D80B49.md)
- 2010-09-30 to 2010-12-31 | money | quarterly_operating_income | 235,616,000 United States dollar | superseded | [clm_868435731BF8](/claim/clm_868435731BF8.md)
- 2010-09-30 to 2010-12-31 | money | quarterly_research_and_development | 94,720,000 United States dollar | superseded | [clm_C343A2AC4D43](/claim/clm_C343A2AC4D43.md)
- 2010-09-30 to 2010-12-31 | money | quarterly_revenue | 682,342,000 United States dollar | superseded | [clm_A6F05D868CAF](/claim/clm_A6F05D868CAF.md)
- 2010-09-30 to 2010-12-31 | money | total_assets | 4,002,865,000 United States dollar | superseded | [clm_A95C670E39B6](/claim/clm_A95C670E39B6.md)
- 2010-09-30 to 2010-12-31 | money | total_equity | 2,341,257,000 United States dollar | superseded | [clm_F29886886B57](/claim/clm_F29886886B57.md)
- 2010-10-13 to 2011-01-13 | money | shares_outstanding | 167,064,459 shares | superseded | [clm_07CFC30043D4](/claim/clm_07CFC30043D4.md)
- 2010-12-31 to 2011-03-31 | money | cash_and_equivalents | 596,104,000 United States dollar | superseded | [clm_1DF58F1D7FC8](/claim/clm_1DF58F1D7FC8.md)
- 2010-12-31 to 2011-03-31 | money | quarterly_net_income | 185,492,000 United States dollar | superseded | [clm_54939D5D1C20](/claim/clm_54939D5D1C20.md)
- 2010-12-31 to 2011-03-31 | money | quarterly_operating_income | 268,866,000 United States dollar | superseded | [clm_A47801F565FF](/claim/clm_A47801F565FF.md)
- 2010-12-31 to 2011-03-31 | money | quarterly_research_and_development | 94,897,000 United States dollar | superseded | [clm_DF2F8C23E4DF](/claim/clm_DF2F8C23E4DF.md)
- 2010-12-31 to 2011-03-31 | money | quarterly_revenue | 766,327,000 United States dollar | superseded | [clm_E7C392FCF014](/claim/clm_E7C392FCF014.md)
- 2010-12-31 to 2011-03-31 | money | total_assets | 4,168,461,000 United States dollar | superseded | [clm_570AB8827ACC](/claim/clm_570AB8827ACC.md)
- 2010-12-31 to 2011-03-31 | money | total_equity | 2,466,234,000 United States dollar | superseded | [clm_A034B0E2815A](/claim/clm_A034B0E2815A.md)

## 2011

- 2011-01-13 to 2011-04-14 | money | shares_outstanding | 167,221,198 shares | superseded | [clm_856A301D1D03](/claim/clm_856A301D1D03.md)
- 2011-03-31 to 2011-06-30 | money | cash_and_equivalents | 638,758,000 United States dollar | superseded | [clm_9AAC1CD341C2](/claim/clm_9AAC1CD341C2.md)
- 2011-03-31 to 2011-09-30 | money | quarterly_net_income | 209,783,000 United States dollar | superseded | [clm_0B100AC3363D](/claim/clm_0B100AC3363D.md)
- 2011-03-31 to 2011-09-30 | money | quarterly_operating_income | 311,779,000 United States dollar | superseded | [clm_C80DE4B60BF6](/claim/clm_C80DE4B60BF6.md)
- 2011-03-31 to 2011-09-30 | money | quarterly_research_and_development | 95,617,000 United States dollar | superseded | [clm_E351B92C3BC7](/claim/clm_E351B92C3BC7.md)
- 2011-03-31 to 2011-09-30 | money | quarterly_revenue | 834,059,000 United States dollar | superseded | [clm_2569B6461E52](/claim/clm_2569B6461E52.md)
- 2011-03-31 to 2011-06-30 | money | total_assets | 4,449,343,000 United States dollar | superseded | [clm_3F91C0EE727C](/claim/clm_3F91C0EE727C.md)
- 2011-03-31 to 2011-06-30 | money | total_equity | 2,673,017,000 United States dollar | superseded | [clm_24510BEEBCD5](/claim/clm_24510BEEBCD5.md)
- 2011-04-14 to 2011-07-21 | money | shares_outstanding | 167,903,024 shares | superseded | [clm_53B8430F8108](/claim/clm_53B8430F8108.md)
- 2011-06-30 to 2011-09-30 | money | cash_and_equivalents | 711,329,000 United States dollar | superseded | [clm_C03F437A04C5](/claim/clm_C03F437A04C5.md)
- 2011-06-30 to 2012-06-30 | money | net_income | 794,488,000 United States dollar | superseded | [clm_C85128B4E703](/claim/clm_C85128B4E703.md)
- 2011-06-30 to 2012-06-30 | money | operating_income | 1,160,330,000 United States dollar | superseded | [clm_093C4B0A2DAA](/claim/clm_093C4B0A2DAA.md)
- 2011-06-30 to 2012-06-30 | money | research_and_development | 386,163,000 United States dollar | superseded | [clm_7F84453DAFBC](/claim/clm_7F84453DAFBC.md)
- 2011-06-30 to 2012-06-30 | money | revenue | 3,175,167,000 United States dollar | superseded | [clm_DF08D451C984](/claim/clm_DF08D451C984.md)
- 2011-06-30 to 2011-09-30 | money | total_assets | 4,675,521,000 United States dollar | superseded | [clm_A48F0861D706](/claim/clm_A48F0861D706.md)
- 2011-06-30 to 2011-09-30 | money | total_equity | 2,860,893,000 United States dollar | superseded | [clm_CC868BD27B38](/claim/clm_CC868BD27B38.md)
- 2011-07-21 to 2011-10-13 | money | shares_outstanding | 167,000,217 shares | superseded | [clm_A750DB78D7CA](/claim/clm_A750DB78D7CA.md)
- 2011-09-30 to 2011-12-31 | money | cash_and_equivalents | 745,947,000 United States dollar | superseded | [clm_78D7678F3B3F](/claim/clm_78D7678F3B3F.md)
- 2011-09-30 to 2011-12-31 | money | quarterly_net_income | 191,995,000 United States dollar | superseded | [clm_82F83F06FE1A](/claim/clm_82F83F06FE1A.md)
- 2011-09-30 to 2011-12-31 | money | quarterly_operating_income | 254,289,000 United States dollar | superseded | [clm_7C5401EE95DE](/claim/clm_7C5401EE95DE.md)
- 2011-09-30 to 2011-12-31 | money | quarterly_research_and_development | 107,762,000 United States dollar | superseded | [clm_664A82B3EBAB](/claim/clm_664A82B3EBAB.md)
- 2011-09-30 to 2011-12-31 | money | quarterly_revenue | 796,476,000 United States dollar | superseded | [clm_A62E59DE1AA7](/claim/clm_A62E59DE1AA7.md)
- 2011-09-30 to 2011-12-31 | money | total_assets | 4,565,317,000 United States dollar | superseded | [clm_C90A75AC6F07](/claim/clm_C90A75AC6F07.md)
- 2011-09-30 to 2011-12-31 | money | total_equity | 2,934,595,000 United States dollar | superseded | [clm_8E90FCA10538](/claim/clm_8E90FCA10538.md)
- 2011-10-13 to 2012-01-12 | money | shares_outstanding | 166,664,427 shares | superseded | [clm_4DFA6D9F839C](/claim/clm_4DFA6D9F839C.md)
- 2011-12-31 to 2012-03-31 | money | cash_and_equivalents | 824,986,000 United States dollar | superseded | [clm_E37958DDFD5F](/claim/clm_E37958DDFD5F.md)
- 2011-12-31 to 2012-03-31 | money | quarterly_net_income | 110,797,000 United States dollar | superseded | [clm_F63E86AA41AE](/claim/clm_F63E86AA41AE.md)
- 2011-12-31 to 2012-03-31 | money | quarterly_operating_income | 159,463,000 United States dollar | superseded | [clm_CF5C5E9BBA66](/claim/clm_CF5C5E9BBA66.md)
- 2011-12-31 to 2012-03-31 | money | quarterly_research_and_development | 116,363,000 United States dollar | superseded | [clm_58775D08C25A](/claim/clm_58775D08C25A.md)
- 2011-12-31 to 2012-03-31 | money | quarterly_revenue | 642,482,000 United States dollar | superseded | [clm_3DDCED08D1CC](/claim/clm_3DDCED08D1CC.md)
- 2011-12-31 to 2012-03-31 | money | total_assets | 4,700,988,000 United States dollar | superseded | [clm_48A25BF4A95F](/claim/clm_48A25BF4A95F.md)
- 2011-12-31 to 2012-03-31 | money | total_equity | 2,968,472,000 United States dollar | superseded | [clm_4A9D42E58DC2](/claim/clm_4A9D42E58DC2.md)

## 2012

- 2012-01-12 to 2012-04-12 | money | shares_outstanding | 166,732,846 shares | superseded | [clm_84BA14339A6E](/claim/clm_84BA14339A6E.md)
- 2012-03-31 to 2012-06-30 | money | cash_and_equivalents | 763,913,000 United States dollar | superseded | [clm_0F1828A210D9](/claim/clm_0F1828A210D9.md)
- 2012-03-31 to 2012-09-30 | money | quarterly_net_income | 205,346,000 United States dollar | superseded | [clm_709D9B7F83A3](/claim/clm_709D9B7F83A3.md)
- 2012-03-31 to 2012-09-30 | money | quarterly_operating_income | 284,274,000 United States dollar | superseded | [clm_D1EC4FEB6428](/claim/clm_D1EC4FEB6428.md)
- 2012-03-31 to 2012-09-30 | money | quarterly_research_and_development | 110,102,000 United States dollar | superseded | [clm_78B8290C557A](/claim/clm_78B8290C557A.md)
- 2012-03-31 to 2012-09-30 | money | quarterly_revenue | 840,521,000 United States dollar | superseded | [clm_B7A8970DB568](/claim/clm_B7A8970DB568.md)
- 2012-03-31 to 2012-06-30 | money | total_assets | 4,933,204,000 United States dollar | superseded | [clm_C0AA33D86392](/claim/clm_C0AA33D86392.md)
- 2012-03-31 to 2012-06-30 | money | total_equity | 3,158,765,000 United States dollar | superseded | [clm_E0AFE9812430](/claim/clm_E0AFE9812430.md)
- 2012-04-12 to 2012-07-19 | money | shares_outstanding | 167,327,833 shares | superseded | [clm_728D610EED06](/claim/clm_728D610EED06.md)
- 2012-06-30 to 2012-09-30 | money | cash_and_equivalents | 751,294,000 United States dollar | superseded | [clm_915D3604C840](/claim/clm_915D3604C840.md)
- 2012-06-30 to 2013-06-30 | money | net_income | 756,015,000 United States dollar | superseded | [clm_22F8CAE49364](/claim/clm_22F8CAE49364.md)
- 2012-06-30 to 2013-06-30 | money | operating_income | 1,016,325,000 United States dollar | superseded | [clm_BDA0A5FB36D7](/claim/clm_BDA0A5FB36D7.md)
- 2012-06-30 to 2013-06-30 | money | research_and_development | 452,937,000 United States dollar | superseded | [clm_EFC005C12597](/claim/clm_EFC005C12597.md)
- 2012-06-30 to 2013-06-30 | money | revenue | 3,171,944,000 United States dollar | superseded | [clm_6B8F2AD1156F](/claim/clm_6B8F2AD1156F.md)
- 2012-06-30 to 2012-09-30 | money | total_assets | 5,100,308,000 United States dollar | superseded | [clm_04D361323E80](/claim/clm_04D361323E80.md)
- 2012-06-30 to 2012-09-30 | money | total_equity | 3,315,595,000 United States dollar | superseded | [clm_763F34460A24](/claim/clm_763F34460A24.md)
- 2012-07-19 to 2012-10-11 | money | shares_outstanding | 166,516,316 shares | superseded | [clm_E5A7FAFC6606](/claim/clm_E5A7FAFC6606.md)
- 2012-09-30 to 2012-12-31 | money | cash_and_equivalents | 709,942,000 United States dollar | superseded | [clm_02214269D493](/claim/clm_02214269D493.md)
- 2012-09-30 to 2012-12-31 | money | quarterly_net_income | 135,367,000 United States dollar | superseded | [clm_7FA2DBBCE601](/claim/clm_7FA2DBBCE601.md)
- 2012-09-30 to 2012-12-31 | money | quarterly_operating_income | 186,557,000 United States dollar | superseded | [clm_1215ED79C1C5](/claim/clm_1215ED79C1C5.md)
- 2012-09-30 to 2012-12-31 | money | quarterly_research_and_development | 119,742,000 United States dollar | superseded | [clm_6B9E43D194C9](/claim/clm_6B9E43D194C9.md)
- 2012-09-30 to 2012-12-31 | money | quarterly_revenue | 720,709,000 United States dollar | superseded | [clm_4DE5F1B11BD2](/claim/clm_4DE5F1B11BD2.md)
- 2012-09-30 to 2012-12-31 | money | total_assets | 5,065,476,000 United States dollar | superseded | [clm_0249600CAAC8](/claim/clm_0249600CAAC8.md)
- 2012-09-30 to 2012-12-31 | money | total_equity | 3,352,312,000 United States dollar | superseded | [clm_F9A506B85A5F](/claim/clm_F9A506B85A5F.md)
- 2012-10-11 to 2013-01-10 | money | shares_outstanding | 166,515,564 shares | superseded | [clm_DECFA671FE8C](/claim/clm_DECFA671FE8C.md)
- 2012-12-31 to 2013-03-31 | money | cash_and_equivalents | 767,313,000 United States dollar | superseded | [clm_5E3A1DF4178F](/claim/clm_5E3A1DF4178F.md)
- 2012-12-31 to 2013-03-31 | money | quarterly_net_income | 106,630,000 United States dollar | superseded | [clm_B65DF75DCF6A](/claim/clm_B65DF75DCF6A.md)
- 2012-12-31 to 2013-03-31 | money | quarterly_operating_income | 153,247,000 United States dollar | superseded | [clm_556A0B3EE39C](/claim/clm_556A0B3EE39C.md)
- 2012-12-31 to 2013-03-31 | money | quarterly_research_and_development | 121,608,000 United States dollar | superseded | [clm_87EBD322F59D](/claim/clm_87EBD322F59D.md)
- 2012-12-31 to 2013-03-31 | money | quarterly_revenue | 673,011,000 United States dollar | superseded | [clm_392A7D261FE7](/claim/clm_392A7D261FE7.md)
- 2012-12-31 to 2013-03-31 | money | total_assets | 5,068,763,000 United States dollar | superseded | [clm_6FC07FF1A16B](/claim/clm_6FC07FF1A16B.md)
- 2012-12-31 to 2013-03-31 | money | total_equity | 3,361,136,000 United States dollar | superseded | [clm_2AF71A1E16EE](/claim/clm_2AF71A1E16EE.md)

## 2013

- 2013-01-10 to 2013-04-12 | money | shares_outstanding | 166,144,760 shares | superseded | [clm_B2109E42DE73](/claim/clm_B2109E42DE73.md)
- 2013-03-31 to 2013-06-30 | money | cash_and_equivalents | 934,201,000 United States dollar | superseded | [clm_BBAE3ED4CCD6](/claim/clm_BBAE3ED4CCD6.md)
- 2013-03-31 to 2013-09-30 | money | quarterly_net_income | 166,382,000 United States dollar | superseded | [clm_68E3C8AF3E3D](/claim/clm_68E3C8AF3E3D.md)
- 2013-03-31 to 2013-09-30 | money | quarterly_operating_income | 202,246,000 United States dollar | superseded | [clm_730955134922](/claim/clm_730955134922.md)
- 2013-03-31 to 2013-09-30 | money | quarterly_research_and_development | 118,788,000 United States dollar | superseded | [clm_9F747D43497D](/claim/clm_9F747D43497D.md)
- 2013-03-31 to 2013-09-30 | money | quarterly_revenue | 729,029,000 United States dollar | superseded | [clm_0E80B3A7C4CA](/claim/clm_0E80B3A7C4CA.md)
- 2013-03-31 to 2013-06-30 | money | total_assets | 5,194,473,000 United States dollar | superseded | [clm_79E21D04C4BB](/claim/clm_79E21D04C4BB.md)
- 2013-03-31 to 2013-06-30 | money | total_equity | 3,446,383,000 United States dollar | superseded | [clm_71D4BCF57CDA](/claim/clm_71D4BCF57CDA.md)
- 2013-04-12 to 2013-07-18 | money | shares_outstanding | 165,885,681 shares | superseded | [clm_CB353B32D790](/claim/clm_CB353B32D790.md)
- 2013-06-30 to 2013-09-30 | money | cash_and_equivalents | 985,390,000 United States dollar | superseded | [clm_DE34B0DFDA9E](/claim/clm_DE34B0DFDA9E.md)
- 2013-06-30 to 2014-06-30 | money | net_income | 543,149,000 United States dollar | superseded | [clm_EE07FE7188FD](/claim/clm_EE07FE7188FD.md)
- 2013-06-30 to 2014-06-30 | money | operating_income | 729,685,000 United States dollar | superseded | [clm_5921C2E0CAEE](/claim/clm_5921C2E0CAEE.md)
- 2013-06-30 to 2014-06-30 | money | research_and_development | 487,832,000 United States dollar | superseded | [clm_46BC5251921E](/claim/clm_46BC5251921E.md)
- 2013-06-30 to 2014-06-30 | money | revenue | 2,842,781,000 United States dollar | superseded | [clm_37A11D43A357](/claim/clm_37A11D43A357.md)
- 2013-06-30 to 2013-09-30 | money | total_assets | 5,287,357,000 United States dollar | superseded | [clm_9F3C7A7CB4F1](/claim/clm_9F3C7A7CB4F1.md)
- 2013-06-30 to 2013-09-30 | money | total_equity | 3,482,152,000 United States dollar | superseded | [clm_60393D9EA03F](/claim/clm_60393D9EA03F.md)
- 2013-07-18 to 2013-10-11 | money | shares_outstanding | 165,731,911 shares | superseded | [clm_96ECB5AED06C](/claim/clm_96ECB5AED06C.md)
- 2013-08-01 | people | cfo | Bren Higgins | valid | [clm_96D6ADFCDEDA](/claim/clm_96D6ADFCDEDA.md)
- 2013-09-30 to 2013-12-31 | money | cash_and_equivalents | 904,949,000 United States dollar | superseded | [clm_CCB187BA27AF](/claim/clm_CCB187BA27AF.md)
- 2013-09-30 to 2013-12-31 | money | quarterly_net_income | 111,197,000 United States dollar | superseded | [clm_88654E79061F](/claim/clm_88654E79061F.md)
- 2013-09-30 to 2013-12-31 | money | quarterly_operating_income | 149,911,000 United States dollar | superseded | [clm_7EC9F4CEA092](/claim/clm_7EC9F4CEA092.md)
- 2013-09-30 to 2013-12-31 | money | quarterly_research_and_development | 132,273,000 United States dollar | superseded | [clm_D19E8A2DF15C](/claim/clm_D19E8A2DF15C.md)
- 2013-09-30 to 2013-12-31 | money | quarterly_revenue | 658,337,000 United States dollar | superseded | [clm_3615E69DE436](/claim/clm_3615E69DE436.md)
- 2013-09-30 to 2013-12-31 | money | total_assets | 5,283,552,000 United States dollar | superseded | [clm_21EBDCDB3ADF](/claim/clm_21EBDCDB3ADF.md)
- 2013-09-30 to 2013-12-31 | money | total_equity | 3,491,163,000 United States dollar | superseded | [clm_5C7410313B41](/claim/clm_5C7410313B41.md)
- 2013-10-11 to 2014-01-10 | money | shares_outstanding | 166,649,418 shares | superseded | [clm_B0B587CB44A0](/claim/clm_B0B587CB44A0.md)
- 2013-12-31 to 2014-03-31 | money | cash_and_equivalents | 793,382,000 United States dollar | superseded | [clm_591928B3F6B3](/claim/clm_591928B3F6B3.md)
- 2013-12-31 to 2014-03-31 | money | quarterly_net_income | 139,246,000 United States dollar | superseded | [clm_8B9528F1BE44](/claim/clm_8B9528F1BE44.md)
- 2013-12-31 to 2014-03-31 | money | quarterly_operating_income | 187,982,000 United States dollar | superseded | [clm_EE9D684090D8](/claim/clm_EE9D684090D8.md)
- 2013-12-31 to 2014-03-31 | money | quarterly_research_and_development | 134,587,000 United States dollar | superseded | [clm_D5EDACAC5BDC](/claim/clm_D5EDACAC5BDC.md)
- 2013-12-31 to 2014-03-31 | money | quarterly_revenue | 705,129,000 United States dollar | superseded | [clm_23DAE210A773](/claim/clm_23DAE210A773.md)
- 2013-12-31 to 2014-03-31 | money | total_assets | 5,440,734,000 United States dollar | superseded | [clm_BFA5FDED146A](/claim/clm_BFA5FDED146A.md)
- 2013-12-31 to 2014-03-31 | money | total_equity | 3,550,207,000 United States dollar | superseded | [clm_99DECC62C30B](/claim/clm_99DECC62C30B.md)

## 2014

- 2014-01-10 to 2014-04-11 | money | shares_outstanding | 166,577,223 shares | superseded | [clm_5C073F8DBF1D](/claim/clm_5C073F8DBF1D.md)
- 2014-03-31 to 2014-06-30 | money | cash_and_equivalents | 776,223,000 United States dollar | superseded | [clm_95AAF94B8A18](/claim/clm_95AAF94B8A18.md)
- 2014-03-31 to 2014-09-30 | money | quarterly_net_income | 203,581,000 United States dollar | superseded | [clm_B769058789D7](/claim/clm_B769058789D7.md)
- 2014-03-31 to 2014-09-30 | money | quarterly_operating_income | 261,163,000 United States dollar | superseded | [clm_34842DCD3B0A](/claim/clm_34842DCD3B0A.md)
- 2014-03-31 to 2014-09-30 | money | quarterly_research_and_development | 134,161,000 United States dollar | superseded | [clm_84A5558A99FC](/claim/clm_84A5558A99FC.md)
- 2014-03-31 to 2014-09-30 | money | quarterly_revenue | 831,599,000 United States dollar | superseded | [clm_107B4EAD0F69](/claim/clm_107B4EAD0F69.md)
- 2014-03-31 to 2014-06-30 | money | total_assets | 5,486,851,000 United States dollar | superseded | [clm_2120E512173E](/claim/clm_2120E512173E.md)
- 2014-03-31 to 2014-06-30 | money | total_equity | 3,639,928,000 United States dollar | superseded | [clm_8B7F059E87DD](/claim/clm_8B7F059E87DD.md)
- 2014-04-11 to 2014-07-17 | money | shares_outstanding | 165,826,885 shares | superseded | [clm_5B47AEAFD09A](/claim/clm_5B47AEAFD09A.md)
- 2014-06-30 to 2014-09-30 | money | cash_and_equivalents | 630,861,000 United States dollar | superseded | [clm_09FB8FED7885](/claim/clm_09FB8FED7885.md)
- 2014-06-30 to 2015-06-30 | money | net_income | 582,755,000 United States dollar | superseded | [clm_3EDBC81CA81A](/claim/clm_3EDBC81CA81A.md)
- 2014-06-30 | money | operating_income | 772,070,000 United States dollar | valid | [clm_7B19523CD1D0](/claim/clm_7B19523CD1D0.md)
- 2014-06-30 to 2015-06-30 | money | research_and_development | 539,469,000 United States dollar | superseded | [clm_B077B832051C](/claim/clm_B077B832051C.md)
- 2014-06-30 to 2015-06-30 | money | revenue | 2,929,408,000 United States dollar | superseded | [clm_340A9DB9BEE4](/claim/clm_340A9DB9BEE4.md)
- 2014-06-30 to 2014-09-30 | money | total_assets | 5,538,664,000 United States dollar | superseded | [clm_6E064234BFC3](/claim/clm_6E064234BFC3.md)
- 2014-06-30 to 2014-09-30 | money | total_equity | 3,669,346,000 United States dollar | superseded | [clm_AEFEA1079CE6](/claim/clm_AEFEA1079CE6.md)
- 2014-07-17 to 2014-10-10 | money | shares_outstanding | 165,368,152 shares | superseded | [clm_873D07C99209](/claim/clm_873D07C99209.md)
- 2014-09-30 to 2014-12-31 | money | cash_and_equivalents | 669,683,000 United States dollar | superseded | [clm_219865C0321A](/claim/clm_219865C0321A.md)
- 2014-09-30 to 2014-12-31 | money | quarterly_net_income | 72,233,000 United States dollar | superseded | [clm_C8FE2615230A](/claim/clm_C8FE2615230A.md)
- 2014-09-30 to 2014-12-31 | money | quarterly_operating_income | 109,153,000 United States dollar | superseded | [clm_187E0A76460D](/claim/clm_187E0A76460D.md)
- 2014-09-30 to 2014-12-31 | money | quarterly_research_and_development | 143,637,000 United States dollar | superseded | [clm_B7053DDB0024](/claim/clm_B7053DDB0024.md)
- 2014-09-30 to 2014-12-31 | money | quarterly_revenue | 642,901,000 United States dollar | superseded | [clm_1712963AC49D](/claim/clm_1712963AC49D.md)
- 2014-09-30 to 2014-12-31 | money | total_assets | 5,301,572,000 United States dollar | superseded | [clm_8BCCCF799945](/claim/clm_8BCCCF799945.md)
- 2014-09-30 to 2014-12-31 | money | total_equity | 3,529,720,000 United States dollar | superseded | [clm_185BC653A9A1](/claim/clm_185BC653A9A1.md)
- 2014-10-10 to 2015-01-09 | money | shares_outstanding | 164,476,980 shares | superseded | [clm_74C9CB8B39B1](/claim/clm_74C9CB8B39B1.md)
- 2014-12-31 to 2015-03-31 | money | cash_and_equivalents | 584,865,000 United States dollar | superseded | [clm_36421B5CC18D](/claim/clm_36421B5CC18D.md)
- 2014-12-31 to 2015-03-31 | money | quarterly_net_income | 20,268,000 United States dollar | superseded | [clm_66E10714A6A5](/claim/clm_66E10714A6A5.md)
- 2014-12-31 to 2015-03-31 | money | quarterly_operating_income | 154,714,000 United States dollar | superseded | [clm_87CBB3C9D652](/claim/clm_87CBB3C9D652.md)
- 2014-12-31 to 2015-03-31 | money | quarterly_research_and_development | 133,557,000 United States dollar | superseded | [clm_36BC1C933A7B](/claim/clm_36BC1C933A7B.md)
- 2014-12-31 to 2015-03-31 | money | quarterly_revenue | 676,357,000 United States dollar | superseded | [clm_2A32F5D1CF08](/claim/clm_2A32F5D1CF08.md)
- 2014-12-31 to 2015-03-31 | money | total_assets | 4,987,366,000 United States dollar | superseded | [clm_CB93EA284CF2](/claim/clm_CB93EA284CF2.md)
- 2014-12-31 to 2015-03-31 | money | total_equity | 602,139,000 United States dollar | superseded | [clm_5209EB63FBB0](/claim/clm_5209EB63FBB0.md)

## 2015

- 2015-01-09 to 2015-04-10 | money | shares_outstanding | 162,664,930 shares | superseded | [clm_BA60D5493ECF](/claim/clm_BA60D5493ECF.md)
- 2015-03-31 to 2015-06-30 | money | cash_and_equivalents | 621,892,000 United States dollar | superseded | [clm_8A6A24144255](/claim/clm_8A6A24144255.md)
- 2015-03-31 to 2015-09-30 | money | quarterly_net_income | 131,638,000 United States dollar | superseded | [clm_CD6968D9DB48](/claim/clm_CD6968D9DB48.md)
- 2015-03-31 | money | quarterly_operating_income | 194,986,000 United States dollar | valid | [clm_7FF94F8E4C12](/claim/clm_7FF94F8E4C12.md)
- 2015-03-31 to 2015-09-30 | money | quarterly_research_and_development | 124,583,000 United States dollar | superseded | [clm_CAE1FF69F97A](/claim/clm_CAE1FF69F97A.md)
- 2015-03-31 to 2015-09-30 | money | quarterly_revenue | 738,459,000 United States dollar | superseded | [clm_01B9B45C78F4](/claim/clm_01B9B45C78F4.md)
- 2015-03-31 to 2015-06-30 | money | total_assets | 4,902,220,000 United States dollar | superseded | [clm_C49AAACD30F3](/claim/clm_C49AAACD30F3.md)
- 2015-03-31 to 2015-06-30 | money | total_equity | 493,941,000 United States dollar | superseded | [clm_335A65AD3518](/claim/clm_335A65AD3518.md)
- 2015-04-10 to 2015-07-17 | money | shares_outstanding | 159,921,055 shares | superseded | [clm_039575C3CC5B](/claim/clm_039575C3CC5B.md)
- 2015-06-30 to 2015-09-30 | money | cash_and_equivalents | 838,025,000 United States dollar | superseded | [clm_9C50DA4608CB](/claim/clm_9C50DA4608CB.md)
- 2015-06-30 to 2016-06-30 | money | net_income | 366,158,000 United States dollar | superseded | [clm_0374746A135D](/claim/clm_0374746A135D.md)
- 2015-06-30 to 2016-06-30 | money | research_and_development | 530,616,000 United States dollar | superseded | [clm_34D574F43DB8](/claim/clm_34D574F43DB8.md)
- 2015-06-30 to 2016-06-30 | money | revenue | 2,814,049,000 United States dollar | superseded | [clm_661F5FF55C7F](/claim/clm_661F5FF55C7F.md)
- 2015-06-30 to 2015-09-30 | money | total_assets | 4,826,012,000 United States dollar | superseded | [clm_0FA318F4377F](/claim/clm_0FA318F4377F.md)
- 2015-06-30 to 2015-09-30 | money | total_equity | 421,439,000 United States dollar | superseded | [clm_B37140DFA752](/claim/clm_B37140DFA752.md)
- 2015-07-17 to 2015-10-09 | money | shares_outstanding | 157,530,878 shares | superseded | [clm_B4EF03CEB0FA](/claim/clm_B4EF03CEB0FA.md)
- 2015-09-30 to 2015-12-31 | money | cash_and_equivalents | 763,697,000 United States dollar | superseded | [clm_809FB76FF0C3](/claim/clm_809FB76FF0C3.md)
- 2015-09-30 to 2015-12-31 | money | quarterly_net_income | 104,897,000 United States dollar | superseded | [clm_687764A33809](/claim/clm_687764A33809.md)
- 2015-09-30 to 2015-12-31 | money | quarterly_research_and_development | 119,943,000 United States dollar | superseded | [clm_536CAB6DC2A4](/claim/clm_536CAB6DC2A4.md)
- 2015-09-30 to 2015-12-31 | money | quarterly_revenue | 642,644,000 United States dollar | superseded | [clm_E241581534D9](/claim/clm_E241581534D9.md)
- 2015-09-30 to 2015-12-31 | money | total_assets | 4,571,323,000 United States dollar | superseded | [clm_7444D74201F2](/claim/clm_7444D74201F2.md)
- 2015-09-30 to 2015-12-31 | money | total_equity | 294,441,000 United States dollar | superseded | [clm_DE032B95531F](/claim/clm_DE032B95531F.md)
- 2015-10-09 to 2016-01-15 | money | shares_outstanding | 155,945,694 shares | superseded | [clm_34C2AC46013E](/claim/clm_34C2AC46013E.md)
- 2015-12-31 to 2016-03-31 | money | cash_and_equivalents | 886,591,000 United States dollar | superseded | [clm_164E31B4692F](/claim/clm_164E31B4692F.md)
- 2015-12-31 to 2016-03-31 | money | quarterly_net_income | 152,207,000 United States dollar | superseded | [clm_6D19A3439FF5](/claim/clm_6D19A3439FF5.md)
- 2015-12-31 to 2016-03-31 | money | quarterly_research_and_development | 118,272,000 United States dollar | superseded | [clm_B937B1E6AE51](/claim/clm_B937B1E6AE51.md)
- 2015-12-31 to 2016-03-31 | money | quarterly_revenue | 710,245,000 United States dollar | superseded | [clm_860183199F82](/claim/clm_860183199F82.md)
- 2015-12-31 to 2016-03-31 | money | total_assets | 4,572,516,000 United States dollar | superseded | [clm_853EDF9F12E9](/claim/clm_853EDF9F12E9.md)
- 2015-12-31 to 2016-03-31 | money | total_equity | 365,625,000 United States dollar | superseded | [clm_A67B1603AFE2](/claim/clm_A67B1603AFE2.md)

## 2016

- 2016-01-15 to 2016-04-15 | money | shares_outstanding | 155,664,640 shares | superseded | [clm_2F81FA11804D](/claim/clm_2F81FA11804D.md)
- 2016-03-31 to 2016-06-30 | money | cash_and_equivalents | 925,974,000 United States dollar | superseded | [clm_32FE462F9965](/claim/clm_32FE462F9965.md)
- 2016-03-31 to 2016-09-30 | money | quarterly_net_income | 175,777,000 United States dollar | superseded | [clm_E5B0E87A42B0](/claim/clm_E5B0E87A42B0.md)
- 2016-03-31 to 2016-09-30 | money | quarterly_research_and_development | 115,589,000 United States dollar | superseded | [clm_1C410481E7DE](/claim/clm_1C410481E7DE.md)
- 2016-03-31 to 2016-09-30 | money | quarterly_revenue | 712,433,000 United States dollar | superseded | [clm_24FF90AD3AED](/claim/clm_24FF90AD3AED.md)
- 2016-03-31 to 2016-06-30 | money | total_assets | 4,782,102,000 United States dollar | superseded | [clm_9BFD4C57397F](/claim/clm_9BFD4C57397F.md)
- 2016-03-31 to 2016-06-30 | money | total_equity | 476,572,000 United States dollar | superseded | [clm_034AB6F44367](/claim/clm_034AB6F44367.md)
- 2016-04-15 to 2016-07-15 | money | shares_outstanding | 155,708,389 shares | superseded | [clm_785892B9C274](/claim/clm_785892B9C274.md)
- 2016-06-30 to 2016-09-30 | money | cash_and_equivalents | 1,108,488,000 United States dollar | superseded | [clm_AD8C25DD6946](/claim/clm_AD8C25DD6946.md)
- 2016-06-30 to 2017-06-30 | money | net_income | 704,422,000 United States dollar | superseded | [clm_081B02275ACD](/claim/clm_081B02275ACD.md)
- 2016-06-30 to 2017-06-30 | money | research_and_development | 481,258,000 United States dollar | superseded | [clm_A73E4DF5E136](/claim/clm_A73E4DF5E136.md)
- 2016-06-30 to 2017-06-30 | money | revenue | 2,984,493,000 United States dollar | superseded | [clm_48159EB6AF5B](/claim/clm_48159EB6AF5B.md)
- 2016-06-30 to 2016-09-30 | money | total_assets | 4,962,432,000 United States dollar | superseded | [clm_C1DFF5668E33](/claim/clm_C1DFF5668E33.md)
- 2016-06-30 to 2016-09-30 | money | total_equity | 689,114,000 United States dollar | superseded | [clm_9897D4C840F9](/claim/clm_9897D4C840F9.md)
- 2016-07-15 to 2016-10-10 | money | shares_outstanding | 155,995,003 shares | superseded | [clm_61EF4CEBDA0D](/claim/clm_61EF4CEBDA0D.md)
- 2016-09-30 to 2016-12-31 | money | cash_and_equivalents | 966,325,000 United States dollar | superseded | [clm_D374F7D8D63E](/claim/clm_D374F7D8D63E.md)
- 2016-09-30 to 2016-12-31 | money | quarterly_net_income | 178,101,000 United States dollar | superseded | [clm_B72D35BDB271](/claim/clm_B72D35BDB271.md)
- 2016-09-30 to 2016-12-31 | money | quarterly_research_and_development | 129,233,000 United States dollar | superseded | [clm_042730CAD713](/claim/clm_042730CAD713.md)
- 2016-09-30 to 2016-12-31 | money | quarterly_revenue | 750,673,000 United States dollar | superseded | [clm_F14764CDCEE7](/claim/clm_F14764CDCEE7.md)
- 2016-09-30 to 2016-12-31 | money | total_assets | 4,996,098,000 United States dollar | superseded | [clm_8F12DE2276EE](/claim/clm_8F12DE2276EE.md)
- 2016-09-30 to 2016-12-31 | money | total_equity | 781,509,000 United States dollar | superseded | [clm_59F64E5B0FEA](/claim/clm_59F64E5B0FEA.md)
- 2016-10-10 to 2017-01-17 | money | shares_outstanding | 156,318,732 shares | superseded | [clm_842109EB72F7](/claim/clm_842109EB72F7.md)
- 2016-12-31 to 2017-03-31 | money | cash_and_equivalents | 937,033,000 United States dollar | superseded | [clm_B29FCDCD98A1](/claim/clm_B29FCDCD98A1.md)
- 2016-12-31 to 2017-03-31 | money | quarterly_net_income | 238,251,000 United States dollar | superseded | [clm_EB06FB271C23](/claim/clm_EB06FB271C23.md)
- 2016-12-31 to 2017-03-31 | money | quarterly_research_and_development | 130,912,000 United States dollar | superseded | [clm_384846AB3DEA](/claim/clm_384846AB3DEA.md)
- 2016-12-31 to 2017-03-31 | money | quarterly_revenue | 876,885,000 United States dollar | superseded | [clm_5053420D5B49](/claim/clm_5053420D5B49.md)
- 2016-12-31 to 2017-03-31 | money | total_assets | 5,094,456,000 United States dollar | superseded | [clm_D652E860BCF1](/claim/clm_D652E860BCF1.md)
- 2016-12-31 to 2017-03-31 | money | total_equity | 965,096,000 United States dollar | superseded | [clm_2EE2B173379A](/claim/clm_2EE2B173379A.md)

## 2017

- 2017-01-17 to 2017-04-14 | money | shares_outstanding | 156,729,320 shares | superseded | [clm_6F685DA76087](/claim/clm_6F685DA76087.md)
- 2017-03-31 to 2017-06-30 | money | cash_and_equivalents | 955,807,000 United States dollar | superseded | [clm_9CA4AEC63A8B](/claim/clm_9CA4AEC63A8B.md)
- 2017-03-31 to 2017-09-30 | money | quarterly_net_income | 253,562,000 United States dollar | superseded | [clm_DD7F94E38753](/claim/clm_DD7F94E38753.md)
- 2017-03-31 to 2017-09-30 | money | quarterly_research_and_development | 130,170,000 United States dollar | superseded | [clm_5D4C7E3FCA3A](/claim/clm_5D4C7E3FCA3A.md)
- 2017-03-31 to 2017-09-30 | money | quarterly_revenue | 913,809,000 United States dollar | superseded | [clm_CAECE75F7F86](/claim/clm_CAECE75F7F86.md)
- 2017-03-31 to 2017-06-30 | money | total_assets | 5,324,445,000 United States dollar | superseded | [clm_B45176A7D6BE](/claim/clm_B45176A7D6BE.md)
- 2017-03-31 to 2017-06-30 | money | total_equity | 1,147,312,000 United States dollar | superseded | [clm_8B245D3D37E4](/claim/clm_8B245D3D37E4.md)
- 2017-04-14 to 2017-07-14 | money | shares_outstanding | 156,762,623 shares | superseded | [clm_3E68E2CE80D8](/claim/clm_3E68E2CE80D8.md)
- 2017-06-30 to 2017-09-30 | money | cash_and_equivalents | 1,153,051,000 United States dollar | superseded | [clm_17CF0A8D62DF](/claim/clm_17CF0A8D62DF.md)
- 2017-06-30 to 2018-06-30 | money | net_income | 926,076,000 United States dollar | superseded | [clm_7E3A8ABF7337](/claim/clm_7E3A8ABF7337.md)
- 2017-06-30 to 2018-06-30 | money | research_and_development | 526,870,000 United States dollar | superseded | [clm_329CBACB3AC2](/claim/clm_329CBACB3AC2.md)
- 2017-06-30 to 2018-06-30 | money | revenue | 3,480,014,000 United States dollar | superseded | [clm_6C848CC215D4](/claim/clm_6C848CC215D4.md)
- 2017-06-30 to 2017-09-30 | money | total_assets | 5,532,173,000 United States dollar | superseded | [clm_D56532AC376C](/claim/clm_D56532AC376C.md)
- 2017-06-30 to 2017-09-30 | money | total_equity | 1,326,417,000 United States dollar | superseded | [clm_A5DC5310AA14](/claim/clm_A5DC5310AA14.md)
- 2017-07-14 to 2017-10-13 | money | shares_outstanding | 156,840,420 shares | superseded | [clm_05910FB4B230](/claim/clm_05910FB4B230.md)
- 2017-09-30 to 2017-12-31 | money | cash_and_equivalents | 1,320,697,000 United States dollar | superseded | [clm_C12FAE6240BD](/claim/clm_C12FAE6240BD.md)
- 2017-09-30 to 2017-12-31 | money | quarterly_net_income | 280,936,000 United States dollar | superseded | [clm_DAF7215B7952](/claim/clm_DAF7215B7952.md)
- 2017-09-30 to 2017-12-31 | money | quarterly_research_and_development | 146,732,000 United States dollar | superseded | [clm_2767C73A5A3C](/claim/clm_2767C73A5A3C.md)
- 2017-09-30 to 2017-12-31 | money | quarterly_revenue | 969,581,000 United States dollar | superseded | [clm_FB5C9E041A7F](/claim/clm_FB5C9E041A7F.md)
- 2017-09-30 to 2017-12-31 | money | total_assets | 5,690,398,000 United States dollar | superseded | [clm_40B2B6B87695](/claim/clm_40B2B6B87695.md)
- 2017-09-30 to 2017-12-31 | money | total_equity | 1,463,956,000 United States dollar | superseded | [clm_C361277297E9](/claim/clm_C361277297E9.md)
- 2017-10-13 to 2018-01-12 | money | shares_outstanding | 156,707,903 shares | superseded | [clm_7B389268FEE7](/claim/clm_7B389268FEE7.md)
- 2017-12-31 to 2018-03-31 | money | cash_and_equivalents | 1,073,394,000 United States dollar | superseded | [clm_DE9FA4ADC0DB](/claim/clm_DE9FA4ADC0DB.md)
- 2017-12-31 to 2018-03-31 | money | quarterly_net_income | -134,319,000 United States dollar | superseded | [clm_18CC0DC42C6E](/claim/clm_18CC0DC42C6E.md)
- 2017-12-31 to 2018-03-31 | money | quarterly_research_and_development | 156,745,000 United States dollar | superseded | [clm_7E93F0FB1F71](/claim/clm_7E93F0FB1F71.md)
- 2017-12-31 to 2018-03-31 | money | quarterly_revenue | 975,822,000 United States dollar | superseded | [clm_817ABDDB63DF](/claim/clm_817ABDDB63DF.md)
- 2017-12-31 to 2018-03-31 | money | total_assets | 5,407,268,000 United States dollar | superseded | [clm_8DD058819623](/claim/clm_8DD058819623.md)
- 2017-12-31 to 2018-03-31 | money | total_equity | 1,225,625,000 United States dollar | superseded | [clm_AB2DB12A40DC](/claim/clm_AB2DB12A40DC.md)

## 2018

- 2018-01-12 to 2018-04-13 | money | shares_outstanding | 156,620,125 shares | superseded | [clm_EA840299BF0B](/claim/clm_EA840299BF0B.md)
- 2018-03-31 to 2018-06-30 | money | cash_and_equivalents | 1,255,682,000 United States dollar | superseded | [clm_114864DDF9A6](/claim/clm_114864DDF9A6.md)
- 2018-03-31 to 2018-09-30 | money | quarterly_net_income | 306,881,000 United States dollar | superseded | [clm_A5D0FA7E51A6](/claim/clm_A5D0FA7E51A6.md)
- 2018-03-31 to 2018-09-30 | money | quarterly_research_and_development | 153,284,000 United States dollar | superseded | [clm_0AEBB0BC08CA](/claim/clm_0AEBB0BC08CA.md)
- 2018-03-31 to 2018-09-30 | money | quarterly_revenue | 1,021,294,000 United States dollar | superseded | [clm_3E6175DEBF2D](/claim/clm_3E6175DEBF2D.md)
- 2018-03-31 to 2018-06-30 | money | total_assets | 5,598,184,000 United States dollar | superseded | [clm_7487A989D4F1](/claim/clm_7487A989D4F1.md)
- 2018-03-31 to 2018-06-30 | money | total_equity | 1,370,143,000 United States dollar | superseded | [clm_84AAB9F0B7E1](/claim/clm_84AAB9F0B7E1.md)
- 2018-04-13 to 2018-07-13 | money | shares_outstanding | 155,872,083 shares | superseded | [clm_90AC522029A5](/claim/clm_90AC522029A5.md)
- 2018-06-30 to 2018-09-30 | money | cash_and_equivalents | 1,404,382,000 United States dollar | superseded | [clm_C2E63C70C168](/claim/clm_C2E63C70C168.md)
- 2018-06-30 to 2019-06-30 | money | net_income | 802,265,000 United States dollar | superseded | [clm_30F099F7B2AB](/claim/clm_30F099F7B2AB.md)
- 2018-06-30 to 2019-06-30 | money | research_and_development | 608,712,000 United States dollar | superseded | [clm_7AB1EF2F881B](/claim/clm_7AB1EF2F881B.md)
- 2018-06-30 to 2019-06-30 | money | revenue | 4,036,701,000 United States dollar | superseded | [clm_0FAA99CA190C](/claim/clm_0FAA99CA190C.md)
- 2018-06-30 to 2018-09-30 | money | total_assets | 5,619,356,000 United States dollar | superseded | [clm_14A40AF9A8EB](/claim/clm_14A40AF9A8EB.md)
- 2018-06-30 to 2018-09-30 | money | total_equity | 1,620,511,000 United States dollar | superseded | [clm_C2FB3EA77F49](/claim/clm_C2FB3EA77F49.md)
- 2018-07-13 to 2018-10-19 | money | shares_outstanding | 156,126,508 shares | superseded | [clm_0D3D03438765](/claim/clm_0D3D03438765.md)
- 2018-09-30 to 2018-12-31 | money | cash_and_equivalents | 1,649,514,000 United States dollar | superseded | [clm_0441EC65632E](/claim/clm_0441EC65632E.md)
- 2018-09-30 to 2018-12-31 | money | quarterly_net_income | 395,944,000 United States dollar | superseded | [clm_47B08095536F](/claim/clm_47B08095536F.md)
- 2018-09-30 to 2018-12-31 | money | quarterly_research_and_development | 153,530,000 United States dollar | superseded | [clm_8B1CCE088B2E](/claim/clm_8B1CCE088B2E.md)
- 2018-09-30 to 2018-12-31 | money | quarterly_revenue | 1,093,260,000 United States dollar | superseded | [clm_C9335DBBF460](/claim/clm_C9335DBBF460.md)
- 2018-09-30 to 2018-12-31 | money | total_assets | 5,645,109,000 United States dollar | superseded | [clm_7E4402864824](/claim/clm_7E4402864824.md)
- 2018-09-30 to 2018-12-31 | money | total_equity | 1,567,369,000 United States dollar | superseded | [clm_C8486E2B944F](/claim/clm_C8486E2B944F.md)
- 2018-10-19 to 2019-01-18 | money | shares_outstanding | 153,075,310 shares | superseded | [clm_CC06BFB7D7AC](/claim/clm_CC06BFB7D7AC.md)
- 2018-12-31 to 2019-03-31 | money | cash_and_equivalents | 1,793,982,000 United States dollar | superseded | [clm_0030E1723550](/claim/clm_0030E1723550.md)
- 2018-12-31 to 2019-03-31 | money | quarterly_net_income | 369,100,000 United States dollar | superseded | [clm_E84E0C46D1C0](/claim/clm_E84E0C46D1C0.md)
- 2018-12-31 to 2019-03-31 | money | quarterly_research_and_development | 165,903,000 United States dollar | superseded | [clm_F6BB9FCF5539](/claim/clm_F6BB9FCF5539.md)
- 2018-12-31 to 2019-03-31 | money | quarterly_revenue | 1,119,898,000 United States dollar | superseded | [clm_8E04EB196D2F](/claim/clm_8E04EB196D2F.md)
- 2018-12-31 to 2019-03-31 | money | total_assets | 5,605,287,000 United States dollar | superseded | [clm_C4C0C1EAF744](/claim/clm_C4C0C1EAF744.md)
- 2018-12-31 to 2019-03-31 | money | total_equity | 1,597,622,000 United States dollar | superseded | [clm_ADBE90BFA0FB](/claim/clm_ADBE90BFA0FB.md)

## 2019

- 2019-01-18 to 2019-04-19 | money | shares_outstanding | 151,363,988 shares | superseded | [clm_FD89F6BF7309](/claim/clm_FD89F6BF7309.md)
- 2019-03-31 to 2019-06-30 | money | cash_and_equivalents | 1,092,163,000 United States dollar | superseded | [clm_798B1F10E037](/claim/clm_798B1F10E037.md)
- 2019-03-31 to 2019-09-30 | money | quarterly_net_income | 192,728,000 United States dollar | superseded | [clm_BC052BBB0762](/claim/clm_BC052BBB0762.md)
- 2019-03-31 to 2019-09-30 | money | quarterly_research_and_development | 184,887,000 United States dollar | superseded | [clm_AED955979708](/claim/clm_AED955979708.md)
- 2019-03-31 to 2019-09-30 | money | quarterly_revenue | 1,097,311,000 United States dollar | superseded | [clm_2DA9104B1FA7](/claim/clm_2DA9104B1FA7.md)
- 2019-03-31 to 2019-06-30 | money | total_assets | 9,187,605,000 United States dollar | superseded | [clm_54A5F54919BB](/claim/clm_54A5F54919BB.md)
- 2019-03-31 to 2019-06-30 | money | total_equity | 2,849,093,000 United States dollar | superseded | [clm_EC91F0D2802B](/claim/clm_EC91F0D2802B.md)
- 2019-04-19 to 2019-07-19 | money | shares_outstanding | 161,620,262 shares | superseded | [clm_3B482E094665](/claim/clm_3B482E094665.md)
- 2019-06-30 to 2019-09-30 | money | cash_and_equivalents | 1,015,994,000 United States dollar | superseded | [clm_8D95A27DC45B](/claim/clm_8D95A27DC45B.md)
- 2019-06-30 to 2020-06-30 | money | net_income | 1,175,617,000 United States dollar | superseded | [clm_77D75B497995](/claim/clm_77D75B497995.md)
- 2019-06-30 to 2020-06-30 | money | research_and_development | 711,030,000 United States dollar | superseded | [clm_E68F5F1776E7](/claim/clm_E68F5F1776E7.md)
- 2019-06-30 to 2020-06-30 | money | revenue | 4,568,904,000 United States dollar | superseded | [clm_DB7A0C7FE244](/claim/clm_DB7A0C7FE244.md)
- 2019-06-30 to 2019-09-30 | money | total_assets | 9,008,516,000 United States dollar | superseded | [clm_0EC852AE6701](/claim/clm_0EC852AE6701.md)
- 2019-06-30 to 2019-09-30 | money | total_equity | 2,659,108,000 United States dollar | superseded | [clm_EB808E69C12C](/claim/clm_EB808E69C12C.md)
- 2019-07-03 | other | registrant_name | KLA CORP | valid | [clm_91DA59C7C96F](/claim/clm_91DA59C7C96F.md)
- 2019-07-19 to 2019-10-18 | money | shares_outstanding | 159,255,950 shares | superseded | [clm_07EF21101A28](/claim/clm_07EF21101A28.md)
- 2019-09-30 to 2019-12-31 | money | cash_and_equivalents | 988,348,000 United States dollar | superseded | [clm_FD8FF2285811](/claim/clm_FD8FF2285811.md)
- 2019-09-30 to 2019-12-31 | money | quarterly_net_income | 346,525,000 United States dollar | superseded | [clm_6C02E2A3AD97](/claim/clm_6C02E2A3AD97.md)
- 2019-09-30 to 2019-12-31 | money | quarterly_research_and_development | 210,580,000 United States dollar | superseded | [clm_87CB65341ADE](/claim/clm_87CB65341ADE.md)
- 2019-09-30 to 2019-12-31 | money | quarterly_revenue | 1,413,414,000 United States dollar | superseded | [clm_6D76E4298E53](/claim/clm_6D76E4298E53.md)
- 2019-09-30 to 2019-12-31 | money | total_assets | 9,229,399,000 United States dollar | superseded | [clm_C889A71FDF56](/claim/clm_C889A71FDF56.md)
- 2019-09-30 to 2019-12-31 | money | total_equity | 2,661,163,000 United States dollar | superseded | [clm_8317380EEEF8](/claim/clm_8317380EEEF8.md)
- 2019-10-18 to 2020-01-17 | money | shares_outstanding | 157,794,495 shares | superseded | [clm_83BA4FB4B77D](/claim/clm_83BA4FB4B77D.md)
- 2019-12-31 to 2020-03-31 | money | cash_and_equivalents | 939,864,000 United States dollar | superseded | [clm_D37D0934CEE2](/claim/clm_D37D0934CEE2.md)
- 2019-12-31 to 2020-03-31 | money | quarterly_net_income | 380,555,000 United States dollar | superseded | [clm_9A5BA0AC00DB](/claim/clm_9A5BA0AC00DB.md)
- 2019-12-31 to 2020-03-31 | money | quarterly_research_and_development | 220,751,000 United States dollar | superseded | [clm_5B8F7EB03EF1](/claim/clm_5B8F7EB03EF1.md)
- 2019-12-31 to 2020-03-31 | money | quarterly_revenue | 1,509,453,000 United States dollar | superseded | [clm_86673FD05B8A](/claim/clm_86673FD05B8A.md)
- 2019-12-31 to 2020-03-31 | money | total_assets | 9,250,720,000 United States dollar | superseded | [clm_F75B4FB604F6](/claim/clm_F75B4FB604F6.md)
- 2019-12-31 to 2020-03-31 | money | total_equity | 2,669,764,000 United States dollar | superseded | [clm_69CFB116339E](/claim/clm_69CFB116339E.md)

## 2020

- 2020-01-17 to 2020-04-20 | money | shares_outstanding | 156,772,198 shares | superseded | [clm_CBBE004A6E9F](/claim/clm_CBBE004A6E9F.md)
- 2020-03-31 to 2020-06-30 | money | cash_and_equivalents | 946,175,000 United States dollar | superseded | [clm_D535164D2DB6](/claim/clm_D535164D2DB6.md)
- 2020-03-31 to 2020-09-30 | money | quarterly_net_income | 78,452,000 United States dollar | superseded | [clm_306E0D02E3F1](/claim/clm_306E0D02E3F1.md)
- 2020-03-31 to 2020-09-30 | money | quarterly_research_and_development | 215,433,000 United States dollar | superseded | [clm_2B6800F068D9](/claim/clm_2B6800F068D9.md)
- 2020-03-31 to 2020-09-30 | money | quarterly_revenue | 1,423,964,000 United States dollar | superseded | [clm_686F113576AC](/claim/clm_686F113576AC.md)
- 2020-03-31 to 2020-06-30 | money | total_assets | 8,845,946,000 United States dollar | superseded | [clm_C249567DC0AC](/claim/clm_C249567DC0AC.md)
- 2020-03-31 to 2020-06-30 | money | total_equity | 2,307,433,000 United States dollar | superseded | [clm_6AA50AE2D56D](/claim/clm_6AA50AE2D56D.md)
- 2020-04-20 to 2020-07-20 | money | shares_outstanding | 155,048,894 shares | superseded | [clm_739C10A7DFFD](/claim/clm_739C10A7DFFD.md)
- 2020-06-30 to 2020-09-30 | money | cash_and_equivalents | 1,234,409,000 United States dollar | superseded | [clm_196678D5ED29](/claim/clm_196678D5ED29.md)
- 2020-06-30 to 2021-06-30 | money | net_income | 1,216,785,000 United States dollar | superseded | [clm_F204BC19E48E](/claim/clm_F204BC19E48E.md)
- 2020-06-30 to 2021-06-30 | money | research_and_development | 863,864,000 United States dollar | superseded | [clm_5A534D647030](/claim/clm_5A534D647030.md)
- 2020-06-30 to 2021-06-30 | money | revenue | 5,806,424,000 United States dollar | superseded | [clm_C2E56A7BFF2F](/claim/clm_C2E56A7BFF2F.md)
- 2020-06-30 to 2020-09-30 | money | total_assets | 9,279,960,000 United States dollar | superseded | [clm_8BA565E53D27](/claim/clm_8BA565E53D27.md)
- 2020-06-30 to 2020-09-30 | money | total_equity | 2,665,424,000 United States dollar | superseded | [clm_EA1C04D5BD97](/claim/clm_EA1C04D5BD97.md)
- 2020-07-20 to 2020-10-19 | money | shares_outstanding | 155,461,444 shares | superseded | [clm_1BF44534D39E](/claim/clm_1BF44534D39E.md)
- 2020-09-30 to 2020-12-31 | money | cash_and_equivalents | 1,215,820,000 United States dollar | superseded | [clm_CF61D825E373](/claim/clm_CF61D825E373.md)
- 2020-09-30 to 2020-12-31 | money | quarterly_net_income | 420,567,000 United States dollar | superseded | [clm_ED8CF1E079E9](/claim/clm_ED8CF1E079E9.md)
- 2020-09-30 to 2020-12-31 | money | quarterly_research_and_development | 219,038,000 United States dollar | superseded | [clm_E9FF495C631E](/claim/clm_E9FF495C631E.md)
- 2020-09-30 to 2020-12-31 | money | quarterly_revenue | 1,538,620,000 United States dollar | superseded | [clm_599F3E1AFD74](/claim/clm_599F3E1AFD74.md)
- 2020-09-30 to 2020-12-31 | money | total_assets | 9,320,096,000 United States dollar | superseded | [clm_F3A32CEFA79D](/claim/clm_F3A32CEFA79D.md)
- 2020-09-30 to 2020-12-31 | money | total_equity | 2,747,184,000 United States dollar | superseded | [clm_A0C13695AC2C](/claim/clm_A0C13695AC2C.md)
- 2020-10-19 to 2021-01-15 | money | shares_outstanding | 154,459,817 shares | superseded | [clm_B3D4FCF55256](/claim/clm_B3D4FCF55256.md)
- 2020-12-31 to 2021-03-31 | money | cash_and_equivalents | 1,431,466,000 United States dollar | superseded | [clm_2E5303A5EB14](/claim/clm_2E5303A5EB14.md)
- 2020-12-31 to 2021-03-31 | money | quarterly_net_income | 457,251,000 United States dollar | superseded | [clm_F07873114A70](/claim/clm_F07873114A70.md)
- 2020-12-31 to 2021-03-31 | money | quarterly_research_and_development | 229,064,000 United States dollar | superseded | [clm_9F05B00D61B5](/claim/clm_9F05B00D61B5.md)
- 2020-12-31 to 2021-03-31 | money | quarterly_revenue | 1,650,870,000 United States dollar | superseded | [clm_CD852563596A](/claim/clm_CD852563596A.md)
- 2020-12-31 to 2021-03-31 | money | total_assets | 9,814,644,000 United States dollar | superseded | [clm_D26E8DE5AC76](/claim/clm_D26E8DE5AC76.md)
- 2020-12-31 to 2021-03-31 | money | total_equity | 2,935,182,000 United States dollar | superseded | [clm_11FB1DB30DFC](/claim/clm_11FB1DB30DFC.md)

## 2021

- 2021-01-15 to 2021-04-19 | money | shares_outstanding | 154,074,651 shares | superseded | [clm_0B31AFD8950E](/claim/clm_0B31AFD8950E.md)
- 2021-03-31 to 2021-06-30 | money | cash_and_equivalents | 1,452,150,000 United States dollar | superseded | [clm_E126F4694041](/claim/clm_E126F4694041.md)
- 2021-03-31 to 2021-09-30 | money | quarterly_net_income | 567,496,000 United States dollar | superseded | [clm_ABA5C9584E4C](/claim/clm_ABA5C9584E4C.md)
- 2021-03-31 to 2021-09-30 | money | quarterly_research_and_development | 238,957,000 United States dollar | superseded | [clm_202794CB875B](/claim/clm_202794CB875B.md)
- 2021-03-31 to 2021-09-30 | money | quarterly_revenue | 1,803,773,000 United States dollar | superseded | [clm_DA0416BB88E1](/claim/clm_DA0416BB88E1.md)
- 2021-03-31 to 2021-06-30 | money | total_assets | 9,939,240,000 United States dollar | superseded | [clm_E2B8ABC656BD](/claim/clm_E2B8ABC656BD.md)
- 2021-03-31 to 2021-06-30 | money | total_equity | 3,114,856,000 United States dollar | superseded | [clm_2EE14DDFBC9B](/claim/clm_2EE14DDFBC9B.md)
- 2021-04-19 to 2021-07-19 | money | shares_outstanding | 153,281,783 shares | superseded | [clm_C83F960FAF29](/claim/clm_C83F960FAF29.md)
- 2021-06-30 to 2021-09-30 | money | cash_and_equivalents | 1,434,610,000 United States dollar | superseded | [clm_2F5C5A09F0F8](/claim/clm_2F5C5A09F0F8.md)
- 2021-06-30 to 2022-06-30 | money | net_income | 2,078,292,000 United States dollar | superseded | [clm_34A18426DF7B](/claim/clm_34A18426DF7B.md)
- 2021-06-30 to 2022-06-30 | money | research_and_development | 928,487,000 United States dollar | superseded | [clm_1B181DB48B8F](/claim/clm_1B181DB48B8F.md)
- 2021-06-30 to 2022-06-30 | money | revenue | 6,918,734,000 United States dollar | superseded | [clm_D072516DDA55](/claim/clm_D072516DDA55.md)
- 2021-06-30 to 2021-09-30 | money | total_assets | 10,271,124,000 United States dollar | superseded | [clm_49657C8AC62E](/claim/clm_49657C8AC62E.md)
- 2021-06-30 to 2021-09-30 | money | total_equity | 3,377,554,000 United States dollar | superseded | [clm_19B5B94B9DFF](/claim/clm_19B5B94B9DFF.md)
- 2021-07-19 to 2021-10-18 | money | shares_outstanding | 152,737,157 shares | superseded | [clm_E2C74AC7090F](/claim/clm_E2C74AC7090F.md)
- 2021-09-30 to 2021-12-31 | money | cash_and_equivalents | 1,509,564,000 United States dollar | superseded | [clm_572E0F21EAA9](/claim/clm_572E0F21EAA9.md)
- 2021-09-30 to 2021-12-31 | money | quarterly_net_income | 1,068,417,000 United States dollar | superseded | [clm_58C324B91789](/claim/clm_58C324B91789.md)
- 2021-09-30 to 2021-12-31 | money | quarterly_research_and_development | 258,153,000 United States dollar | superseded | [clm_300C51FB29E2](/claim/clm_300C51FB29E2.md)
- 2021-09-30 to 2021-12-31 | money | quarterly_revenue | 2,083,838,000 United States dollar | superseded | [clm_7211FA01296A](/claim/clm_7211FA01296A.md)
- 2021-09-30 to 2021-12-31 | money | total_assets | 11,146,477,000 United States dollar | superseded | [clm_1091D0B478DC](/claim/clm_1091D0B478DC.md)
- 2021-09-30 to 2021-12-31 | money | total_equity | 3,860,930,000 United States dollar | superseded | [clm_8FD6BF7DEBD8](/claim/clm_8FD6BF7DEBD8.md)
- 2021-10-18 to 2022-01-14 | money | shares_outstanding | 151,622,165 shares | superseded | [clm_CEDDDFF82BAB](/claim/clm_CEDDDFF82BAB.md)
- 2021-12-31 to 2022-03-31 | money | cash_and_equivalents | 1,657,057,000 United States dollar | superseded | [clm_304DE6A3384B](/claim/clm_304DE6A3384B.md)
- 2021-12-31 to 2022-03-31 | money | quarterly_net_income | 717,444,000 United States dollar | superseded | [clm_09522751E716](/claim/clm_09522751E716.md)
- 2021-12-31 to 2022-03-31 | money | quarterly_research_and_development | 265,031,000 United States dollar | superseded | [clm_20441C7F79A2](/claim/clm_20441C7F79A2.md)
- 2021-12-31 to 2022-03-31 | money | quarterly_revenue | 2,352,630,000 United States dollar | superseded | [clm_8FA1FB2181B9](/claim/clm_8FA1FB2181B9.md)
- 2021-12-31 to 2022-03-31 | money | total_assets | 11,680,237,000 United States dollar | superseded | [clm_4894A4FE994F](/claim/clm_4894A4FE994F.md)
- 2021-12-31 to 2022-03-31 | money | total_equity | 4,048,527,000 United States dollar | superseded | [clm_4054F521CA5B](/claim/clm_4054F521CA5B.md)

## 2022

- 2022-01-14 to 2022-04-18 | money | shares_outstanding | 150,715,343 shares | superseded | [clm_A19033B4C6F4](/claim/clm_A19033B4C6F4.md)
- 2022-03-31 to 2022-06-30 | money | cash_and_equivalents | 1,415,172,000 United States dollar | superseded | [clm_CFE0ED6F53A7](/claim/clm_CFE0ED6F53A7.md)
- 2022-03-31 to 2022-09-30 | money | quarterly_net_income | 730,572,000 United States dollar | superseded | [clm_EEEF222781BF](/claim/clm_EEEF222781BF.md)
- 2022-03-31 to 2022-09-30 | money | quarterly_research_and_development | 285,189,000 United States dollar | superseded | [clm_3F261192DB21](/claim/clm_3F261192DB21.md)
- 2022-03-31 to 2022-09-30 | money | quarterly_revenue | 2,288,676,000 United States dollar | superseded | [clm_05658C2E3795](/claim/clm_05658C2E3795.md)
- 2022-03-31 to 2022-06-30 | money | total_assets | 12,017,812,000 United States dollar | superseded | [clm_F6A3191FAC3E](/claim/clm_F6A3191FAC3E.md)
- 2022-03-31 to 2022-06-30 | money | total_equity | 4,080,307,000 United States dollar | superseded | [clm_6D6F88078913](/claim/clm_6D6F88078913.md)
- 2022-04-18 to 2022-07-18 | money | shares_outstanding | 149,235,049 shares | superseded | [clm_1025EE42239F](/claim/clm_1025EE42239F.md)
- 2022-06-30 to 2022-09-30 | money | cash_and_equivalents | 1,584,908,000 United States dollar | superseded | [clm_CE9CFF5B00D6](/claim/clm_CE9CFF5B00D6.md)
- 2022-06-30 to 2023-06-30 | money | net_income | 3,321,807,000 United States dollar | superseded | [clm_4697A2B85B24](/claim/clm_4697A2B85B24.md)
- 2022-06-30 to 2023-06-30 | money | research_and_development | 1,105,254,000 United States dollar | superseded | [clm_B47653A2479F](/claim/clm_B47653A2479F.md)
- 2022-06-30 to 2023-06-30 | money | revenue | 9,211,883,000 United States dollar | superseded | [clm_1B8634AFFE00](/claim/clm_1B8634AFFE00.md)
- 2022-06-30 to 2022-09-30 | money | total_assets | 12,597,088,000 United States dollar | superseded | [clm_C64CAA7C59E1](/claim/clm_C64CAA7C59E1.md)
- 2022-06-30 to 2022-09-30 | money | total_equity | 1,401,351,000 United States dollar | superseded | [clm_182B7EDCE944](/claim/clm_182B7EDCE944.md)
- 2022-07-18 to 2022-10-17 | money | shares_outstanding | 141,803,776 shares | superseded | [clm_F9D7B0EF75BC](/claim/clm_F9D7B0EF75BC.md)
- 2022-09-30 to 2022-12-31 | money | cash_and_equivalents | 1,819,280,000 United States dollar | superseded | [clm_8875B86D0D80](/claim/clm_8875B86D0D80.md)
- 2022-09-30 to 2022-12-31 | money | quarterly_net_income | 1,025,991,000 United States dollar | superseded | [clm_4D4A93160698](/claim/clm_4D4A93160698.md)
- 2022-09-30 to 2022-12-31 | money | quarterly_research_and_development | 318,515,000 United States dollar | superseded | [clm_A5CAF266C9EC](/claim/clm_A5CAF266C9EC.md)
- 2022-09-30 to 2022-12-31 | money | quarterly_revenue | 2,724,424,000 United States dollar | superseded | [clm_7F80A3B2A033](/claim/clm_7F80A3B2A033.md)
- 2022-09-30 to 2022-12-31 | money | total_assets | 13,123,652,000 United States dollar | superseded | [clm_7BAA9FB71CCC](/claim/clm_7BAA9FB71CCC.md)
- 2022-09-30 to 2022-12-31 | money | total_equity | 2,102,074,000 United States dollar | superseded | [clm_F770D22B10F4](/claim/clm_F770D22B10F4.md)
- 2022-10-17 to 2023-01-17 | money | shares_outstanding | 141,718,327 shares | superseded | [clm_28EF2B82F847](/claim/clm_28EF2B82F847.md)
- 2022-11-01 | people | chair | Robert Calderoni | valid | [clm_1DA5BC249216](/claim/clm_1DA5BC249216.md)
- 2022-12-31 to 2023-03-31 | money | cash_and_equivalents | 1,571,477,000 United States dollar | superseded | [clm_7F8E31DC5574](/claim/clm_7F8E31DC5574.md)
- 2022-12-31 to 2023-03-31 | money | quarterly_net_income | 978,795,000 United States dollar | superseded | [clm_09532EDDE1F9](/claim/clm_09532EDDE1F9.md)
- 2022-12-31 to 2023-03-31 | money | quarterly_research_and_development | 332,826,000 United States dollar | superseded | [clm_6D607BAB165C](/claim/clm_6D607BAB165C.md)
- 2022-12-31 to 2023-03-31 | money | quarterly_revenue | 2,983,887,000 United States dollar | superseded | [clm_2BDFF5BFE759](/claim/clm_2BDFF5BFE759.md)
- 2022-12-31 to 2023-03-31 | money | total_assets | 13,729,074,000 United States dollar | superseded | [clm_20448CAEB120](/claim/clm_20448CAEB120.md)
- 2022-12-31 to 2023-03-31 | money | total_equity | 2,603,260,000 United States dollar | superseded | [clm_1082592841D4](/claim/clm_1082592841D4.md)

## 2023

- 2023-01-17 to 2023-04-17 | money | shares_outstanding | 138,479,764 shares | superseded | [clm_A973AD724887](/claim/clm_A973AD724887.md)
- 2023-03-31 to 2023-06-30 | money | cash_and_equivalents | 1,568,513,000 United States dollar | superseded | [clm_551254BE0C45](/claim/clm_551254BE0C45.md)
- 2023-03-31 to 2023-09-30 | money | quarterly_net_income | 697,837,000 United States dollar | superseded | [clm_DC599C720406](/claim/clm_DC599C720406.md)
- 2023-03-31 to 2023-09-30 | money | quarterly_research_and_development | 328,276,000 United States dollar | superseded | [clm_639E227D7D89](/claim/clm_639E227D7D89.md)
- 2023-03-31 to 2023-09-30 | money | quarterly_revenue | 2,432,608,000 United States dollar | superseded | [clm_87B456DF54FA](/claim/clm_87B456DF54FA.md)
- 2023-03-31 to 2023-06-30 | money | total_assets | 13,683,549,000 United States dollar | superseded | [clm_BA611AAE3CF4](/claim/clm_BA611AAE3CF4.md)
- 2023-03-31 to 2023-06-30 | money | total_equity | 2,682,781,000 United States dollar | superseded | [clm_721545623724](/claim/clm_721545623724.md)
- 2023-04-17 to 2023-07-17 | money | shares_outstanding | 137,198,902 shares | superseded | [clm_060D1CC228AF](/claim/clm_060D1CC228AF.md)
- 2023-06-30 to 2023-09-30 | money | cash_and_equivalents | 1,927,865,000 United States dollar | superseded | [clm_808900115D30](/claim/clm_808900115D30.md)
- 2023-06-30 to 2024-06-30 | money | net_income | 3,387,277,000 United States dollar | superseded | [clm_0E601B0347C2](/claim/clm_0E601B0347C2.md)
- 2023-06-30 to 2024-06-30 | money | research_and_development | 1,296,727,000 United States dollar | superseded | [clm_16E178EE281E](/claim/clm_16E178EE281E.md)
- 2023-06-30 to 2024-06-30 | money | revenue | 10,496,056,000 United States dollar | superseded | [clm_77723BEE2CA4](/claim/clm_77723BEE2CA4.md)
- 2023-06-30 to 2023-09-30 | money | total_assets | 14,072,357,000 United States dollar | superseded | [clm_0001297E1DF7](/claim/clm_0001297E1DF7.md)
- 2023-06-30 to 2023-09-30 | money | total_equity | 2,919,753,000 United States dollar | superseded | [clm_D90734BB78AF](/claim/clm_D90734BB78AF.md)
- 2023-07-17 to 2023-10-16 | money | shares_outstanding | 136,720,074 shares | superseded | [clm_9C0F366F26F9](/claim/clm_9C0F366F26F9.md)
- 2023-09-30 to 2023-12-31 | money | cash_and_equivalents | 1,711,570,000 United States dollar | superseded | [clm_A43EE7EAD37D](/claim/clm_A43EE7EAD37D.md)
- 2023-09-30 to 2023-12-31 | money | quarterly_net_income | 741,375,000 United States dollar | superseded | [clm_4E363CE35F84](/claim/clm_4E363CE35F84.md)
- 2023-09-30 to 2023-12-31 | money | quarterly_research_and_development | 311,214,000 United States dollar | superseded | [clm_9FB8FFD0A233](/claim/clm_9FB8FFD0A233.md)
- 2023-09-30 to 2023-12-31 | money | quarterly_revenue | 2,396,956,000 United States dollar | superseded | [clm_4344AF61C226](/claim/clm_4344AF61C226.md)
- 2023-09-30 to 2023-12-31 | money | total_assets | 14,136,841,000 United States dollar | superseded | [clm_D06E42883692](/claim/clm_D06E42883692.md)
- 2023-09-30 to 2023-12-31 | money | total_equity | 2,990,217,000 United States dollar | superseded | [clm_2A72F6ABE523](/claim/clm_2A72F6ABE523.md)
- 2023-10-16 to 2024-01-16 | money | shares_outstanding | 135,932,316 shares | superseded | [clm_E943DFC38F67](/claim/clm_E943DFC38F67.md)
- 2023-12-31 to 2024-03-31 | money | cash_and_equivalents | 1,665,054,000 United States dollar | superseded | [clm_8BFCC5495081](/claim/clm_8BFCC5495081.md)
- 2023-12-31 to 2024-03-31 | money | quarterly_net_income | 582,534,000 United States dollar | superseded | [clm_54FAFD8D15D0](/claim/clm_54FAFD8D15D0.md)
- 2023-12-31 to 2024-03-31 | money | quarterly_research_and_development | 320,418,000 United States dollar | superseded | [clm_86B4B0E0B1A5](/claim/clm_86B4B0E0B1A5.md)
- 2023-12-31 to 2024-03-31 | money | quarterly_revenue | 2,486,726,000 United States dollar | superseded | [clm_967DB406A5F6](/claim/clm_967DB406A5F6.md)
- 2023-12-31 to 2024-03-31 | money | total_assets | 14,280,501,000 United States dollar | superseded | [clm_6602CA97F948](/claim/clm_6602CA97F948.md)
- 2023-12-31 to 2024-03-31 | money | total_equity | 3,043,711,000 United States dollar | superseded | [clm_86FC08D40332](/claim/clm_86FC08D40332.md)

## 2024

- 2024-01-16 to 2024-04-15 | money | shares_outstanding | 135,233,651 shares | superseded | [clm_3211BC012E56](/claim/clm_3211BC012E56.md)
- 2024-03-31 to 2024-06-30 | money | cash_and_equivalents | 1,848,167,000 United States dollar | superseded | [clm_B96C423F6C99](/claim/clm_B96C423F6C99.md)
- 2024-03-31 to 2024-09-30 | money | quarterly_net_income | 601,541,000 United States dollar | superseded | [clm_2AE4D7163529](/claim/clm_2AE4D7163529.md)
- 2024-03-31 to 2024-09-30 | money | quarterly_research_and_development | 321,590,000 United States dollar | superseded | [clm_6174D17363F5](/claim/clm_6174D17363F5.md)
- 2024-03-31 to 2024-09-30 | money | quarterly_revenue | 2,359,830,000 United States dollar | superseded | [clm_0B429564BAC5](/claim/clm_0B429564BAC5.md)
- 2024-03-31 to 2024-06-30 | money | total_assets | 14,957,289,000 United States dollar | superseded | [clm_A12F463C28F8](/claim/clm_A12F463C28F8.md)
- 2024-03-31 to 2024-06-30 | money | total_equity | 3,094,885,000 United States dollar | superseded | [clm_B2CD367122D6](/claim/clm_B2CD367122D6.md)
- 2024-04-15 to 2024-07-22 | money | shares_outstanding | 134,639,951 shares | superseded | [clm_5799B3C76C95](/claim/clm_5799B3C76C95.md)
- 2024-06-30 to 2024-09-30 | money | cash_and_equivalents | 1,977,129,000 United States dollar | superseded | [clm_C84769B7F670](/claim/clm_C84769B7F670.md)
- 2024-06-30 to 2025-06-30 | money | net_income | 2,761,896,000 United States dollar | superseded | [clm_507ABA6D8041](/claim/clm_507ABA6D8041.md)
- 2024-06-30 to 2025-06-30 | money | research_and_development | 1,278,981,000 United States dollar | superseded | [clm_4BFDE3417725](/claim/clm_4BFDE3417725.md)
- 2024-06-30 to 2025-06-30 | money | revenue | 9,812,247,000 United States dollar | superseded | [clm_C697A7ACBE4A](/claim/clm_C697A7ACBE4A.md)
- 2024-06-30 to 2024-09-30 | money | total_assets | 15,433,566,000 United States dollar | superseded | [clm_E23D2E454EBC](/claim/clm_E23D2E454EBC.md)
- 2024-06-30 to 2024-09-30 | money | total_equity | 3,368,328,000 United States dollar | superseded | [clm_664645C8744A](/claim/clm_664645C8744A.md)
- 2024-07-22 to 2024-10-21 | money | shares_outstanding | 134,425,022 shares | superseded | [clm_8010B53850CE](/claim/clm_8010B53850CE.md)
- 2024-09-30 to 2024-12-31 | money | cash_and_equivalents | 1,977,202,000 United States dollar | superseded | [clm_C2EB50FAF4C0](/claim/clm_C2EB50FAF4C0.md)
- 2024-09-30 to 2024-12-31 | money | quarterly_net_income | 945,851,000 United States dollar | superseded | [clm_492BD0984794](/claim/clm_492BD0984794.md)
- 2024-09-30 to 2024-12-31 | money | quarterly_research_and_development | 323,145,000 United States dollar | superseded | [clm_DD9D37FA9E6E](/claim/clm_DD9D37FA9E6E.md)
- 2024-09-30 to 2024-12-31 | money | quarterly_revenue | 2,841,541,000 United States dollar | superseded | [clm_FC4D059F92C9](/claim/clm_FC4D059F92C9.md)
- 2024-09-30 to 2024-12-31 | money | total_assets | 15,681,737,000 United States dollar | superseded | [clm_4A8CCAC95104](/claim/clm_4A8CCAC95104.md)
- 2024-09-30 to 2024-12-31 | money | total_equity | 3,559,714,000 United States dollar | superseded | [clm_91687371F995](/claim/clm_91687371F995.md)
- 2024-10-21 to 2025-01-21 | money | shares_outstanding | 133,759,778 shares | superseded | [clm_96D458B5DC4A](/claim/clm_96D458B5DC4A.md)
- 2024-12-31 to 2025-03-31 | money | cash_and_equivalents | 1,838,278,000 United States dollar | superseded | [clm_883F9348F3CC](/claim/clm_883F9348F3CC.md)
- 2024-12-31 to 2025-03-31 | money | quarterly_net_income | 824,527,000 United States dollar | superseded | [clm_DE05A965DB18](/claim/clm_DE05A965DB18.md)
- 2024-12-31 to 2025-03-31 | money | quarterly_research_and_development | 346,157,000 United States dollar | superseded | [clm_130757F282ED](/claim/clm_130757F282ED.md)
- 2024-12-31 to 2025-03-31 | money | quarterly_revenue | 3,076,851,000 United States dollar | superseded | [clm_A8B90A231850](/claim/clm_A8B90A231850.md)
- 2024-12-31 to 2025-03-31 | money | total_assets | 15,001,696,000 United States dollar | superseded | [clm_8E6A47DE4F1A](/claim/clm_8E6A47DE4F1A.md)
- 2024-12-31 to 2025-03-31 | money | total_equity | 3,584,549,000 United States dollar | superseded | [clm_A68A97CDA516](/claim/clm_A68A97CDA516.md)

## 2025

- 2025-01-21 to 2025-04-21 | money | shares_outstanding | 132,886,746 shares | superseded | [clm_2328B05FC4BF](/claim/clm_2328B05FC4BF.md)
- 2025-03-31 to 2025-06-30 | money | cash_and_equivalents | 1,858,022,000 United States dollar | superseded | [clm_E12915FCDD4C](/claim/clm_E12915FCDD4C.md)
- 2025-03-31 to 2025-09-30 | money | quarterly_net_income | 1,088,416,000 United States dollar | superseded | [clm_E4A8A3C75269](/claim/clm_E4A8A3C75269.md)
- 2025-03-31 to 2025-09-30 | money | quarterly_research_and_development | 338,043,000 United States dollar | superseded | [clm_12E71FF20C1E](/claim/clm_12E71FF20C1E.md)
- 2025-03-31 to 2025-09-30 | money | quarterly_revenue | 3,063,029,000 United States dollar | superseded | [clm_5C5A5C2E83DC](/claim/clm_5C5A5C2E83DC.md)
- 2025-03-31 to 2025-06-30 | money | total_assets | 15,188,307,000 United States dollar | superseded | [clm_259AEBD9C560](/claim/clm_259AEBD9C560.md)
- 2025-03-31 to 2025-06-30 | money | total_equity | 4,004,739,000 United States dollar | superseded | [clm_0E6A0AAEF8E1](/claim/clm_0E6A0AAEF8E1.md)
- 2025-04-21 to 2025-07-21 | money | shares_outstanding | 132,241,430 shares | superseded | [clm_135B6CB37338](/claim/clm_135B6CB37338.md)
- 2025-06-30 to 2025-09-30 | money | cash_and_equivalents | 2,078,908,000 United States dollar | superseded | [clm_E25A95958C8C](/claim/clm_E25A95958C8C.md)
- 2025-06-30 to 2026-06-30 | money | net_income | 4,061,643,000 United States dollar | superseded | [clm_99DCF66CD13F](/claim/clm_99DCF66CD13F.md)
- 2025-06-30 to 2026-06-30 | money | research_and_development | 1,360,334,000 United States dollar | superseded | [clm_532B12CBC6E7](/claim/clm_532B12CBC6E7.md)
- 2025-06-30 to 2026-06-30 | money | revenue | 12,156,162,000 United States dollar | superseded | [clm_237142B6E965](/claim/clm_237142B6E965.md)
- 2025-06-30 to 2025-09-30 | money | total_assets | 16,067,926,000 United States dollar | superseded | [clm_DF078A89C3BD](/claim/clm_DF078A89C3BD.md)
- 2025-06-30 to 2025-09-30 | money | total_equity | 4,692,453,000 United States dollar | superseded | [clm_029237583A0F](/claim/clm_029237583A0F.md)
- 2025-07-21 to 2025-10-27 | money | shares_outstanding | 131,961,370 shares | superseded | [clm_DFF6A1B13982](/claim/clm_DFF6A1B13982.md)
- 2025-09-30 to 2025-12-31 | money | cash_and_equivalents | 1,946,211,000 United States dollar | superseded | [clm_A86A1EB8DDEB](/claim/clm_A86A1EB8DDEB.md)
- 2025-09-30 to 2025-12-31 | money | quarterly_net_income | 1,121,040,000 United States dollar | superseded | [clm_EE5914AB74C4](/claim/clm_EE5914AB74C4.md)
- 2025-09-30 to 2025-12-31 | money | quarterly_research_and_development | 360,461,000 United States dollar | superseded | [clm_8083DDBFFE83](/claim/clm_8083DDBFFE83.md)
- 2025-09-30 to 2025-12-31 | money | quarterly_revenue | 3,209,696,000 United States dollar | superseded | [clm_55331C4EBB4B](/claim/clm_55331C4EBB4B.md)
- 2025-09-30 to 2025-12-31 | money | total_assets | 16,317,974,000 United States dollar | superseded | [clm_A093C6479EEA](/claim/clm_A093C6479EEA.md)
- 2025-09-30 to 2025-12-31 | money | total_equity | 4,985,071,000 United States dollar | superseded | [clm_9E68C1170DBC](/claim/clm_9E68C1170DBC.md)
- 2025-10-27 to 2026-01-26 | money | shares_outstanding | 131,392,338 shares | superseded | [clm_F6AFF3E16982](/claim/clm_F6AFF3E16982.md)
- 2025-12-31 to 2026-03-31 | money | cash_and_equivalents | 2,452,124,000 United States dollar | superseded | [clm_5B07B36FCA50](/claim/clm_5B07B36FCA50.md)
- 2025-12-31 to 2026-03-31 | money | quarterly_net_income | 1,145,682,000 United States dollar | superseded | [clm_370865B2F2CC](/claim/clm_370865B2F2CC.md)
- 2025-12-31 to 2026-03-31 | money | quarterly_research_and_development | 383,871,000 United States dollar | superseded | [clm_03723860DCBD](/claim/clm_03723860DCBD.md)
- 2025-12-31 to 2026-03-31 | money | quarterly_revenue | 3,297,146,000 United States dollar | superseded | [clm_93EA1FCB2B2E](/claim/clm_93EA1FCB2B2E.md)
- 2025-12-31 to 2026-03-31 | money | total_assets | 16,720,228,000 United States dollar | superseded | [clm_5A953F8C2320](/claim/clm_5A953F8C2320.md)
- 2025-12-31 to 2026-03-31 | money | total_equity | 5,465,731,000 United States dollar | superseded | [clm_BF2A189DD3C0](/claim/clm_BF2A189DD3C0.md)

## 2026

- 2026-01-26 to 2026-04-27 | money | shares_outstanding | 131,076,611 shares | superseded | [clm_206F70990CDD](/claim/clm_206F70990CDD.md)
- 2026-03-31 to 2026-06-30 | money | cash_and_equivalents | 1,787,010,000 United States dollar | superseded | [clm_3CF6D87EEFB6](/claim/clm_3CF6D87EEFB6.md)
- 2026-03-31 to 2026-09-30 | money | quarterly_net_income | 1,200,990,000 United States dollar | superseded | [clm_3520FA3553E3](/claim/clm_3520FA3553E3.md)
- 2026-03-31 to 2026-09-30 | money | quarterly_research_and_development | 388,763,000 United States dollar | superseded | [clm_E66C8B6E9AD4](/claim/clm_E66C8B6E9AD4.md)
- 2026-03-31 to 2026-09-30 | money | quarterly_revenue | 3,415,078,000 United States dollar | superseded | [clm_1BF600B5F47A](/claim/clm_1BF600B5F47A.md)
- 2026-03-31 to 2026-06-30 | money | total_assets | 16,873,515,000 United States dollar | superseded | [clm_6F095A7A1B06](/claim/clm_6F095A7A1B06.md)
- 2026-03-31 to 2026-06-30 | money | total_equity | 5,830,495,000 United States dollar | superseded | [clm_1DE4A65782CB](/claim/clm_1DE4A65782CB.md)
- 2026-04-27 to 2026-08-03 | money | shares_outstanding | 130,627,521 shares | superseded | [clm_E1B5D42380B1](/claim/clm_E1B5D42380B1.md)
- 2026-06-30 to 2026-09-30 | money | cash_and_equivalents | 1,649,842,000 United States dollar | superseded | [clm_5A7A1238F123](/claim/clm_5A7A1238F123.md)
- 2026-06-30 | money | net_income | 4,830,771,000 United States dollar | valid | [clm_0623F6F0682F](/claim/clm_0623F6F0682F.md)
- 2026-06-30 | money | research_and_development | 1,532,118,000 United States dollar | valid | [clm_D095790E0875](/claim/clm_D095790E0875.md)
- 2026-06-30 | money | revenue | 13,579,476,000 United States dollar | valid | [clm_4F4CB1A8672C](/claim/clm_4F4CB1A8672C.md)
- 2026-06-30 to 2026-09-30 | money | total_assets | 17,951,535,000 United States dollar | superseded | [clm_F164C9B302CB](/claim/clm_F164C9B302CB.md)
- 2026-06-30 to 2026-09-30 | money | total_equity | 6,349,820,000 United States dollar | superseded | [clm_08C3374AFF3F](/claim/clm_08C3374AFF3F.md)
- 2026-08-03 to 2026-10-26 | money | shares_outstanding | 1,306,546,783 shares | superseded | [clm_7C281D186A61](/claim/clm_7C281D186A61.md)
- 2026-09-30 | money | cash_and_equivalents | 1,531,950,000 United States dollar | valid | [clm_31511B7F90C6](/claim/clm_31511B7F90C6.md)
- 2026-09-30 | money | quarterly_net_income | 1,548,588,000 United States dollar | valid | [clm_C9A92F3C6D26](/claim/clm_C9A92F3C6D26.md)
- 2026-09-30 | money | quarterly_research_and_development | 395,096,000 United States dollar | valid | [clm_26491E44CBF3](/claim/clm_26491E44CBF3.md)
- 2026-09-30 | money | quarterly_revenue | 4,136,015,000 United States dollar | valid | [clm_C83AEE08C255](/claim/clm_C83AEE08C255.md)
- 2026-09-30 | money | total_assets | 18,404,735,000 United States dollar | valid | [clm_1FE29EB5741E](/claim/clm_1FE29EB5741E.md)
- 2026-09-30 | money | total_equity | 6,523,407,000 United States dollar | valid | [clm_65E5C2CAC952](/claim/clm_65E5C2CAC952.md)
- 2026-10-26 | money | shares_outstanding | 1,302,962,435 shares | valid | [clm_472FE70FFAA0](/claim/clm_472FE70FFAA0.md)

## undated

- undated | other | cik | 0000319201 | valid | [clm_EB245934140A](/claim/clm_EB245934140A.md)
- undated | other | fiscal_year_end | 06-30 | valid | [clm_323E59F97B3C](/claim/clm_323E59F97B3C.md)
- undated | other | headquarters | Milpitas | valid | [clm_5B961F7415B6](/claim/clm_5B961F7415B6.md)
- undated | other | listed_on | Nasdaq | valid | [clm_23DE83BE1D7A](/claim/clm_23DE83BE1D7A.md)
- undated | other | sic_industry | Optical Instruments & Lenses (3827) | valid | [clm_F0A61A5529EA](/claim/clm_F0A61A5529EA.md)
- undated | other | state_of_incorporation | DE | valid | [clm_CD8B7C9A4E03](/claim/clm_CD8B7C9A4E03.md)
- undated | other | ticker | KLAC | valid | [clm_0F6A9C98DA40](/claim/clm_0F6A9C98DA40.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.